Consistent Response on Challenge and Rechallenge of Liposomal Irinotecan in a Patient with Metastatic Pancreatic Adenocarcinoma Previously Treated with Gemcitabine plus Nab-Paclitaxel: A Case Report

Approximately 80% of pancreatic cancer is diagnosed at an advanced stage, due to lack of or vague symptoms when the cancer is still localized, leading to a high mortality rate. Known risk factors for developing pancreatic cancer are family history, obesity, type 2 diabetes, and alcohol and tobacco u...

Descripción completa

Detalles Bibliográficos
Autores principales: Kim, Seong-Ryong, Lee, Hyun Jung, Kim, Dalyong
Formato: Online Artículo Texto
Lenguaje:English
Publicado: S. Karger AG 2021
Materias:
Case Report
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787498/
https://www.ncbi.nlm.nih.gov/pubmed/35111024
http://dx.doi.org/10.1159/000521315

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8787498/
https://www.ncbi.nlm.nih.gov/pubmed/35111024
http://dx.doi.org/10.1159/000521315

Ejemplares similares